The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Stem cells from bone marrow, skeletal muscle and possibly other tissues can be identified by the 'side-population' (SP) phenotype. Although it has been assumed that expression of ABC transporters is responsible for this phenotype, the specific molecules involved have not been defined. Here we show that expression of the Bcrp1 (also known as Abcg2 murine/ABCG2 human) gene is a conserved feature of stem cells from a wide variety of sources. Bcrp1 mRNA was expressed at high levels in primitive murine hematopoietic stem cells, and was sharply downregulated with differentiation. Enforced expression of the ABCG2 cDNA directly conferred the SP phenotype to bone-marrow cells and caused a reduction in maturing progeny both in vitro and in transplantation-based assays. These results show that expression of the Bcrp1/ABCG2 gene is an important determinant of the SP phenotype, and that it might serve as a marker for stem cells from various sources.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Side population cells express ATP-binding cassette transporter (ABCG2/Brcp1) on the cell surface and have the ability to efflux the DNA binding dye Hoechst 33 342 (Zhou et al., 2001).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Zhou et al., 2001
Citations
Cites
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., Finegold, M., Weissman, I. L., & Grompe, M. (2000) · Nature Medicine · doi:10.1038/81326 · Cited by 2,314
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Self-citationDystrophin expression in the mdx mouse restored by stem cell transplantation
Gussoni, E., Soneoka, Y., Strickland, C. D., Buzney, E. A., Khan, M. K., Flint, A. F., Kunkel, L. M., & Mulligan, R. C. (1999) · Nature · doi:10.1038/43919 · Cited by 1,802
Goodell, M. A., Rosenzweig, M., Kim, H., Marks, D. F., DeMaria, M., Paradis, G., Grupp, S. A., Sieff, C. A., Mulligan, R. C., & Johnson, R. P. (1997) · Nature Medicine · doi:10.1038/nm1297-1337 · Cited by 1,089
A safe packaging line for gene transfer: separating viral genes on two different plasmids
Markowitz, D., Goff, S., & Bank, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1120-1124.1988 · Cited by 1,061
Hematopoietic potential of stem cells isolated from murine skeletal muscle
Jackson, K. A., Mi, T., & Goodell, M. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14482 · Cited by 955
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Chaudhary, P. M., & Roninson, I. B. (1991) · Cell · doi:10.1016/0092-8674(91)90141-k · Cited by 934
Cited by
Items 101–200 of 1,005
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T. A., Runge, S., Risbood, M., Poruchynsky, M. S., & Bates, S. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601370 · Cited by 368
Wang, J., Guo, L.-P., Chen, L.-Z., Zeng, Y.-X., & Lu, S. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4343 · Cited by 363
Adult stem cells in the endometrium
Gargett, C. E., & Masuda, H. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq061 · Cited by 361
Jiang, X., Zhao, Y., Smith, C., Gasparetto, M., Turhan, A., Eaves, A., & Eaves, C. (2007) · Leukemia · doi:10.1038/sj.leu.2404609 · Cited by 359
ROLE OF ABCG2/BCRP IN BIOLOGY AND MEDICINE
Krishnamurthy, P., & Schuetz, J. D. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141238 · Cited by 356
Self-citationTamaki, T., Akatsuka, A., Ando, K., Nakamura, Y., Matsuzawa, H., Hotta, T., R Roy, R., & Edgerton, V. R. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112106 · Cited by 350
Beltrami, A. P., Cesselli, D., Bergamin, N., Marcon, P., Rigo, S., Puppato, E., D'Aurizio, F., Verardo, R., Piazza, S., Pignatelli, A., et al. (2007) · Blood · doi:10.1182/blood-2006-11-055566 · Cited by 346
Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Kong, D., Banerjee, S., & Sarkar, F. H. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.07.001 · Cited by 343
Side population cells in human cancers
Wu, C., & Alman, B. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.048 · Cited by 341
ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 341
High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter
Özvegy-Laczka, C., Hegedűs, T., Várady, G., Ujhelly, O., Schuetz, J. D., Váradi, A., Kéri, G., Őrfi, L., Német, K., & Sarkadi, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1485 · Cited by 340
Self-citationDistinctive properties of metastasis-initiating cells
Celià-Terrassa, T., & Kang, Y. (2016) · Genes & Development · doi:10.1101/gad.277681.116 · Cited by 336
“MICs enriched with CSC-like features may benefit from resistant mechanisms of CSCs, such as a stronger DNA damage response (Wang 2015), elevated expression of efflux drug pumps (Schinkel et al. 1994; Zhou et al. 2001; Dean et al. 2005), and ALDH detoxifying enzymes (Honoki et al.”
BackgroundMultipotent Stem Cells in Human Corneal Stroma
Du, Y., Funderburgh, M. L., Mann, M. M., SundarRaj, N., & Funderburgh, J. L. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0256 · Cited by 335
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia
Castor, A., Nilsson, L., Åstrand-Grundström, I., Buitenhuis, M., Ramirez, C., Anderson, K., Strömbeck, B., Garwicz, S., Békássy, A. N., Schmiegelow, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1253 · Cited by 334
Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
Golebiewska, A., Brons, N. H. C., Bjerkvig, R., & Niclou, S. P. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.007 · Cited by 333
Structure and Function of ABC Transporters
Linton, K. J. (2007) · Physiology · doi:10.1152/physiol.00046.2006 · Cited by 329
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Garcia-Mayea, Y., Mir, C., Masson, F., Paciucci, R., & LLeonart, M. E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.022 · Cited by 324
Silica Nanorattle–Doxorubicin-Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy
Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., Meng, X., Fu, C., Li, Y., Qu, Q., Zhang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202399w · Cited by 327
Oyama, T., Nagai, T., Wada, H., Naito, A. T., Matsuura, K., Iwanaga, K., Takahashi, T., Goto, M., Mikami, Y., Yasuda, N., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200603014 · Cited by 325
Structural basis of small-molecule inhibition of human multidrug transporter ABCG2
Jackson, S. M., Manolaridis, I., Kowal, J., Zechner, M., Taylor, N. M. I., Bause, M., Bauer, S., Bartholomaeus, R., Bernhardt, G., Koenig, B., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0049-1 · Cited by 321
ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy
Ding, X.-W., Wu, J.-H., & Jiang, C.-P. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.02.012 · Cited by 323
A putative human breast stem cell population is enriched for steroid receptor-positive cells
Clarke, R. B., Spence, K., Anderson, E., Howell, A., Okano, H., & Potten, C. S. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2004.07.044 · Cited by 321
Asakura, A., & Rudnicki, M. A. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00954-2 · Cited by 318
Mizuarai, S., Aozasa, N., & Kotani, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.11669 · Cited by 318
Marra, A., Trapani, D., Viale, G., Criscitiello, C., & Curigliano, G. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00197-2 · Cited by 317
Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart
Tomita, Y., Matsumura, K., Wakamatsu, Y., Matsuzaki, Y., Shibuya, I., Kawaguchi, H., Ieda, M., Kanakubo, S., Shimazaki, T., Ogawa, S., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504061 · Cited by 318
ABCG2 Transporter Identifies a Population of Clonogenic Human Limbal Epithelial Cells
de Paiva, C. S., Chen, Z., Corrales, R. M., Pflugfelder, S. C., & Li, D. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0093 · Cited by 316
Niche regulation of corneal epithelial stem cells at the limbus
Li, W., Hayashida, Y., Chen, Y.-T., & Tseng, S. C. (2007) · Cell Research · doi:10.1038/sj.cr.7310137 · Cited by 310
Bisson, I., & Prowse, D. M. (2009) · Cell Research · doi:10.1038/cr.2009.43 · Cited by 308
SP analysis may be used to identify cancer stem cell populations
Hadnagy, A., Gaboury, L., Beaulieu, R., & Balicki, D. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.030 · Cited by 306
Masuda, H., Matsuzaki, Y., Hiratsu, E., Ono, M., Nagashima, T., Kajitani, T., Arase, T., Oda, H., Uchida, H., Asada, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010387 · Cited by 303
“Since ESP cells, like other SP cells, expressed the SP-specific marker ABCG2 [15], we performed immunofluorescence staining of human cycling endometrium using ABCG2 antibody to address”
BackgroundMethodInfluentialIohara, K., Zheng, L., Ito, M., Tomokiyo, A., Matsushita, K., & Nakashima, M. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0161 · Cited by 303
Yang, J., Liao, D., Chen, C., Liu, Y., Chuang, T.-H., Xiang, R., Markowitz, D., Reisfeld, R. A., & Luo, Y. (2013) · Stem Cells · doi:10.1002/stem.1281 · Cited by 301
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
Vassalli, G. (2019) · Stem Cells International · doi:10.1155/2019/3904645 · Cited by 300
“SP cells from various types of tissues have been associated with self-renewal and multilineage differentiation capacity [8, 9].”
BackgroundOvarian cancer stem-like side-population cells are tumourigenic and chemoresistant
Hu, L., McArthur, C., & Jaffe, R. B. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605626 · Cited by 296
Adult Stem Cell Plasticity: Fact or Artifact?
Raff, M. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111301.143037 · Cited by 297
Liu, B. Y., McDermott, S. P., Khwaja, S. S., & Alexander, C. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400699101 · Cited by 293
Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
Agarwal, S., Sane, R., Oberoi, R., Ohlfest, J. R., & Elmquist, W. F. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001888 · Cited by 292
Unexpectedly Efficient Homing Capacity of Purified Murine Hematopoietic Stem Cells
Matsuzaki, Y., Kinjo, K., Mulligan, R. C., & Okano, H. (2004) · Immunity · doi:10.1016/s1074-7613(03)00354-6 · Cited by 290
Functional and molecular characterisation of mammary side population cells
Alvi, A. J., Clayton, H., Joshi, C., Enver, T., Ashworth, A., Vivanco, M. A. M., Dale, T. C., & Smalley, M. J. (2002) · Breast Cancer Research · doi:10.1186/bcr547 · Cited by 289
Therapy resistance mediated by cancer stem cells
Steinbichler, T. B., Dudás, J., Skvortsov, S., Ganswindt, U., Riechelmann, H., & Skvortsova, I.-I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.006 · Cited by 286
Differential Expression of Novel Potential Regulators in Hematopoietic Stem Cells
Forsberg, E. C., Prohaska, S. S., Katzman, S., Heffner, G. C., Stuart, J. M., & Weissman, I. L. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010028 · Cited by 285
Pisco, A. O., & Huang, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.146 · Cited by 283
“This scheme of preselection due to non-genetic variability followed by later genetic fixation is in essence Waddington’s genetic assimilation (Waddington, 1942; Zhou et al, 2001; Kim et al, 2002).”
BackgroundABCG2 – a transporter for all seasons
Sarkadi, B., Özvegy-Laczka, C., Német, K., & Váradi, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.123 · Cited by 282
Rao, W., Wang, H., Han, J., Zhao, S., Dumbleton, J., Agarwal, P., Zhang, W., Zhao, G., Yu, J., Zynger, D. L., et al. (2015) · ACS Nano · doi:10.1021/nn506928p · Cited by 281
Zhang, Q., Shi, S., Yen, Y., Brown, J., Ta, J. Q., & Le, A. D. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.08.010 · Cited by 278
Identification and isolation of hematopoietic stem cells
Wognum, A. W., Eaves, A. C., & Thomas, T. E. (2003) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.09.008 · Cited by 276
Amnion-derived pluripotent/multipotent stem cells
Miki, T., & Strom, S. C. (2006) · Stem Cell Reviews · doi:10.1007/s12015-006-0020-0 · Cited by 275
Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
Agarwal, S., M.S. Hartz, A., F. Elmquist, W., & Bauer, B. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440186 · Cited by 272
“In addition, BCRP is highly expressed at the plasma membrane of tumor stem cells [57, 58], where it could be involved in stem cell differentiation, protection against xenobiotics, and cancer cell survival under hypoxic conditions [59].”
BackgroundSide population cells and Bcrp1 expression in lung
Summer, R., Kotton, D. N., Sun, X., Ma, B., Fitzsimmons, K., & Fine, A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2003 · Cited by 275
Zamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D., & Schuetz, E. G. (2003) · Pharmacogenetics · doi:10.1097/00008571-200301000-00004 · Cited by 272
Self-citationLakshmipathy, U., & Verfaillie, C. (2005) · Blood Reviews · doi:10.1016/j.blre.2004.03.001 · Cited by 259
The role of transporters in cellular heme and porphyrin homeostasis
KRISHNAMURTHY, P., XIE, T., & SCHUETZ, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.001 · Cited by 260
Self-citationMultidrug resistance: Physiological principles and nanomedical solutions
Kunjachan, S., Rychlik, B., Storm, G., Kiessling, F., & Lammers, T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.018 · Cited by 259
“ABCG2 is furthermore highly expressed in stem cells of different organs, being responsible for a socalled ‘side-population phenotype’, which is marked by a reduced uptake of Hoechst 33342 [40].”
BackgroundWu, C., Calcagno, A. M., & Ambudkar, S. V. (2008) · Current Molecular Pharmacology · doi:10.2174/1874-470210801020093 · Cited by 259
MDR- and CYP3A4-mediated drug–herbal interactions
Pal, D., & Mitra, A. K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.010 · Cited by 254
Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
Zhou, Y., Zhou, Y., Shingu, T., Feng, L., Chen, Z., Ogasawara, M., Keating, M. J., Kondo, S., & Huang, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.260935 · Cited by 250
Characterisation of dental pulp stem cells: A new horizon for tissue regeneration?
Kawashima, N. (2012) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.08.010 · Cited by 248
“High efflux of a fluorescent nuclear stain A population of stem cells that has the ability to exclude Hoechst dye 33342, a fluorescent DNA binding dye, are defined as side-population (SP) cells.93 Using this technique, an adult stem cell population, which has the ability to differentiate into osteoblasts, chondroblast…”
BackgroundSingh, S., Trevino, J., Bora-Singhal, N., Coppola, D., Haura, E., Altiok, S., & Chellappan, S. P. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-73 · Cited by 250
“SP phenotype is dependent on the differential ability of cells to efflux the Hoechst 33342 dye via the ATP-binding cassette (ABC) family of transporter protein, mainly ABCG2 (breast cancer resistance protein, BRCP1) which is specifically expressed on the cell membrane of stem cell populations [14].”
BackgroundTanaka, K. K., Hall, J. K., Troy, A. A., Cornelison, D. D. W., Majka, S. M., & Olwin, B. B. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.016 · Cited by 249
Ballatori, N., Hammond, C. L., Cunningham, J. B., Krance, S. M., & Marchan, R. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.09.008 · Cited by 247
Cancer stem cell: target for anti‐cancer therapy
Tang, C., Ang, B. T., & Pervaiz, S. (2007) · The FASEB Journal · doi:10.1096/fj.07-8560rev · Cited by 246
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243
Frank, N. Y., Pendse, S. S., Lapchak, P. H., Margaryan, A., Shlain, D., Doeing, C., Sayegh, M. H., & Frank, M. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308700200 · Cited by 242
Mallini, P., Lennard, T., Kirby, J., & Meeson, A. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.008 · Cited by 240
“Zhu and co-workers proposed that BCSCs can also be sorted based on the CD44+/CD24-/EpCAM+ phenotype (Zhu et al., 2012).”
BackgroundSuccessful Therapy Must Eradicate Cancer Stem Cells
Dingli, D., & Michor, F. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0136 · Cited by 241
Characterization of side-population cells in human normal endometrium
Kato, K., Yoshimoto, M., Kato, K., Adachi, S., Yamayoshi, A., Arima, T., Asanoma, K., Kyo, S., Nakahata, T., & Wake, N. (2007) · Human Reproduction · doi:10.1093/humrep/del514 · Cited by 240
Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
Quintás-Cardama, A., Kantarjian, H. M., & Cortes, J. E. (2009) · Cancer Control · doi:10.1177/107327480901600204 · Cited by 238
Targeted therapy for cancer stem cells: the patched pathway and ABC transporters
Lou, H., & Dean, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210200 · Cited by 239
The controversial role of ABC transporters in clinical oncology
Tamaki, A., Ierano, C., Szakacs, G., Robey, R. W., & Bates, S. E. (2011) · Essays in Biochemistry · doi:10.1042/bse0500209 · Cited by 235
“ABCG2 is localized in the hepatocytes of the liver, zona reticularis layer of the adrenal glands, alveolar pneumocytes of the lung, prostate epithelium, uterine endocervical cells, cortical tubules of the kidney, islet and acinar cells in the pancreas, epithelial cells of the gastrointestinal tract and ducts and lobul…”
BackgroundThe Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
Wu, C.-P., Hsieh, C.-H., & Wu, Y.-S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200261n · Cited by 234
Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free Estrogens
Imai, Y., Asada, S., Tsukahara, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.610 · Cited by 235
Beretta, G. L., Cassinelli, G., Pennati, M., Zuco, V., & Gatti, L. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.062 · Cited by 235
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.06.001 · Cited by 233
Cancer stem cells: A contentious hypothesis now moving forward
O’Connor, M. L., Xiang, D., Shigdar, S., Macdonald, J., Li, Y., Wang, T., Pu, C., Wang, Z., Qiao, L., & Duan, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.012 · Cited by 233
“In fact, the presence of ABC transporters has been extensively utilised in isolation of CSCs using a technique known as side populations assays (SP) through the efflux of Hoechst dye [76,77].”
MethodBreast cancer resistance protein (BCRP/ABCG2)
Staud, F., & Pavek, P. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.11.004 · Cited by 232
Budak, M. T., Alpdogan, O. S., Zhou, M., Lavker, R. M., Akinci, M. A. M., & Wolosin, J. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02279 · Cited by 232
Single nucleotide polymorphisms modify the transporter activity of ABCG2
Morisaki, K., Robey, R. W., Özvegy-Laczka, C., Honjo, Y., Polgar, O., Steadman, K., Sarkadi, B., & Bates, S. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0931-x · Cited by 230
Mitsutake, N., Iwao, A., Nagai, K., Namba, H., Ohtsuru, A., Saenko, V., & Yamashita, S. (2007) · Endocrinology · doi:10.1210/en.2006-1553 · Cited by 230
Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states
Manolaridis, I., Jackson, S. M., Taylor, N. M. I., Kowal, J., Stahlberg, H., & Locher, K. P. (2018) · Nature · doi:10.1038/s41586-018-0680-3 · Cited by 228
Hegedűs, C., Özvegy‐Laczka, C., Apáti, Á., Magócsi, M., Német, K., Őrfi, L., Kéri, G., Katona, M., Takáts, Z., Váradi, A., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00383.x · Cited by 228
Elkind, N. B., Szentpétery, Z., Apáti, A., Özvegy-Laczka, C., Várady, G., Ujhelly, O., Szabó, K., Homolya, L., Váradi, A., Buday, L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3303 · Cited by 225
Hwang-Verslues, W. W., Kuo, W.-H., Chang, P.-H., Pan, C.-C., Wang, H.-H., Tsai, S.-T., Jeng, Y.-M., Shew, J.-Y., Kung, J. T., Chen, C.-H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008377 · Cited by 223
ABCG2: structure, function and role in drug response
Polgar, O., Robey, R. W., & Bates, S. E. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.1.1 · Cited by 224
Arai, F., Ohneda, O., Miyamoto, T., Zhang, X. Q., & Suda, T. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011700 · Cited by 223
Verfaillie, C. M., Pera, M. F., & Lansdorp, P. M. (2002) · Hematology · doi:10.1182/asheducation-2002.1.369 · Cited by 222
Side Population Cells Isolated from Mesenchymal Neoplasms Have Tumor Initiating Potential
Wu, C., Wei, Q., Utomo, V., Nadesan, P., Whetstone, H., Kandel, R., Wunder, J. S., & Alman, B. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0999 · Cited by 221
Human ABCG2: structure, function, and its role in multidrug resistance.
Mo, W., & Zhang, J. (2012) · PubMed · Cited by 305
Lee, H. J., Kim, K. S., Kim, E. J., Choi, H. B., Lee, K. H., Park, I. H., Ko, Y., Jeong, S. W., & Kim, S. U. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0409 · Cited by 217
Dohse, M., Scharenberg, C., Shukla, S., Robey, R. W., Volkmann, T., Deeken, J. F., Brendel, C., Ambudkar, S. V., Neubauer, A., & Bates, S. E. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031302 · Cited by 216
Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport
Sims-Mourtada, J., Izzo, J. G., Ajani, J., & Chao, K. S. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210356 · Cited by 217
Most C6 Cells Are Cancer Stem Cells: Evidence from Clonal and Population Analyses
Zheng, X., Shen, G., Yang, X., & Liu, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3912 · Cited by 217
Ee, P. L. R., Kamalakaran, S., Tonetti, D., He, X., Ross, D. D., & Beck, W. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3583 · Cited by 217
Tumorigenesis of Chemotherapeutic Drug-Resistant Cancer Stem-Like Cells in Brain Glioma
Kang, M.-K., & Kang, S.-K. (2007) · Stem Cells and Development · doi:10.1089/scd.2007.0006 · Cited by 215
van Herwaarden, A. E., & Schinkel, A. H. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.007 · Cited by 214
Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
Stacy, A. E., Jansson, P. J., & Richardson, D. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088609 · Cited by 210
“Notably, ABCG2 is also a marker of cancer stem cells, as the efflux of the ABCG2 substrate, Hoechst 33342, is exploited to isolate them (Zhou et al., 2001).”
BackgroundRevisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
K. Tiwari, A., Sodani, K., Dai, C.-L., R. Ashby, C., & Chen, Z.-S. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164048 · Cited by 211
Watanabe, K., Nishida, K., Yamato, M., Umemoto, T., Sumide, T., Yamamoto, K., Maeda, N., Watanabe, H., Okano, T., & Tano, Y. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.064 · Cited by 211
Tiwari, A. K., Sodani, K., Wang, S.-R., Kuang, Y.-H., Ashby, C. R., Chen, X., & Chen, Z.-S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.002 · Cited by 209
Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications
Hiwase, D. K., Saunders, V., Hewett, D., Frede, A., Zrim, S., Dang, P., Eadie, L., To, L. B., Melo, J., Kumar, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5095 · Cited by 208
Metadata
- Authors
- Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., & Sorrentino, B. P.
- Affiliations
- St. Jude Children's Research Hospital (US)
- University of Tsukuba (JP)
- Corresponding author
- Sorrentino, Brian P.
- ORCID
- Venue
- Nature Medicine
- Published
- 2001-09
- Volume
- 7
- Issue
- 9
- Pages
- 1028-1034
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1483167997
- Cited by
- 2,280
- References
- 37
- Citations by year
- 2026: 9 · 2025: 25 · 2024: 28 · 2023: 53 · 2022: 43 · 2021: 44 · 2020: 63 · 2019: 58 · 2018: 72 · 2017: 90 · 2016: 82 · 2015: 100 · 2014: 117 · 2013: 146 · 2012: 142
- FWCI
- 34.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL053749, P01HL53749, R01HL067366, R01-HL67366-01)
- National Cancer Institute (P 30CA 21765, P30CA021765)
- National Institute of General Medical Sciences (GM60904)
- National Institute of Environmental Health Sciences (ES05851)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- ABCG2, BCRP1, ABC transporters, side population cells, stem cells, hematopoietic stem cells, bone marrow, skeletal muscle stem cells, stem cell markers, stem cell differentiation, stem cell transplantation, drug efflux
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Animals, Bone Marrow Cells, Cells, Cultured, Female, Humans, Male, Membrane Glycoproteins, Mice, Inbred Strains, Mice, Mutant Strains, Neoplasm Proteins, Ribosomal Proteins, Stem Cells, Biomarkers, Antigens, CD, Cytokines, ATP-Binding Cassette Transporters, Antigens, CD34, Macrophage Inflammatory Proteins, Transplants, Chemokines, CC, ATP Binding Cassette Transporter, Subfamily B, Member 1, ATP-Binding Cassette, Sub-Family C Proteins, Mice, Tetraspanin 29
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.